Equine Infectious Anemia Virus and the Ubiquitin-Proteasome System

AUTOR(ES)

Ott, David E.

FONTE

American Society for Microbiology

RESUMO

Some retroviruses contain monoubiquitinated Gag and do not bud efficiently from cells treated with proteasome inhibitors, suggesting an interaction between the ubiquitin-proteasome system and retrovirus assembly. We examined equine infectious anemia virus (EIAV) particles and found that approximately 2% of the p9Gag proteins are monoubiquitinated, demonstrating that this Gag protein interacts with an ubiquitinating activity. Different types of proteasome inhibitors were used to determine if proteasome inactivation affects EIAV release from chronically infected cells. Pulse-chase immunoprecipitation and time course immunoblot analyses showed that proteasome inactivation slightly decreased virus release (at most a twofold effect), while it did not affect Gag processing. These results contrast with those obtained with other viruses which are sensitive to these inhibitors. This suggests that, although its Gag is monoubiquitinated, the requirements for EIAV release are somewhat different from those for retroviruses that are sensitive to proteasome inhibitors.

Documentos Relacionados

• Rhabdoviruses and the Cellular Ubiquitin-Proteasome System: a Budding Interaction
• Inhibition of the ubiquitin-proteasome system in Alzheimer's disease
• The Ubiquitin-Proteasome Pathway and Plant Development
• Regulation of nicotinic receptor expression by the ubiquitin–proteasome system
• The Ubiquitin-Proteasome System Facilitates the Transfer of Murine Coronavirus from Endosome to Cytoplasm during Virus Entry